Abstract:Carss, K. J., Deaton, A. M., Del Rio-Espinola, A., Diogo, D., Fielden, M., Kulkarni, D. A., et al. (2023). Using human genetics to improve safety assessment of therapeutics. Nat. Rev. Drug Discov. 22, 145–162. doi: 10.1038/s41573-022-00561-w 10.1038/s41573-022-00561-wSearch in Google Scholar PubMed Cipriani, V., Vestito, L., Magavern, E. F., Jacobsen, J. O., Arno, G., Behr, E. R., et al. (2023). Rare disease gene association discovery from burden analysis of the 100 000 Genomes Project data. 2023.12.20.23300294. doi: 10.1101/2023.12.20.23300294 10.1101/2023.12.20.23300294Search in Google Scholar PubMed PubMed Central Dhandapany, P. S., Sadayappan, S., Xue, Y., Powell, G. T., Rani, D. S., Nallari, P., et al. (2009). A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia. Nat. Genet. 41, 187–191. doi: 10.1038/ng.309 10.1038/ng.309Search in Google Scholar PubMed PubMed Central Dingemans, A. J. M., Hinne, M., Truijen, K. M. G., Goltstein, L., Reeuwijk, J. van, Leeuw, N. de, et al. (2022). PhenoScore: AI-based phenomics to quantify rare disease and genetic variation. 2022.10.24.22281480. doi: 10.1101/2022.10.24.22281480 10.1101/2022.10.24.22281480Search in Google Scholar Dingemans, A. J. M., Jansen, S., Reeuwijk, J. van, Leeuw, N. de, Pfundt, R., Schuurs-Hoeijmakers, J., et al. (2023). PhenomAD-NDD: the Phenomics Aggregation Database of comorbidities in 51,227 pediatric individuals with NeuroDevelopmental Disorders. 2023.11.29.23299167. doi: 10.1101/2023.11.29.23299167 10.1101/2023.11.29.23299167Search in Google Scholar Jaramillo Oquendo, C., Wai, H. A., Rich, W., Bunyan, D. J., Thomas, N. S., Hunt, D., et al. (2023). RNA sequencing uplifts diagnostic rate in undiagnosed rare disease patients. 2023.07.05.23292254. doi: 10.1101/2023.07.05.23292254 10.1101/2023.07.05.23292254Search in Google Scholar Karczewski, K. J., Gupta, R., Kanai, M., Lu, W., Tsuo, K., Wang, Y., et al. (2024). Pan-UK Biobank GWAS improves discovery, analysis of genetic architecture, and resolution into ancestry-enriched effects. 2024.03.13.24303864. doi: 10.1101/2024.03.13.24303864 10.1101/2024.03.13.24303864Search in Google Scholar Kumar, R., Corbett, M. A., Smith, N. J. C., Hock, D. H., Kikhtyak, Z., Semcesen, L. N., et al. (2022). Oligonucleotide correction of an intronic TIMMDC1 variant in cells of patients with severe neurodegenerative disorder. Npj Genomic Med. 7, 1–12. doi: 10.1038/s41525-021-00277-7 10.1038/s41525-021-00277-7Search in Google Scholar PubMed PubMed Central Luo, X., Sun, Y., Xu, F., Guo, J., Li, L., Lin, Z., et al. (2020). A pilot study of expanded newborn screening for 573 genes related to severe inherited disorders in China: results from 1,127 newborns. Ann. Transl. Med. 8, 1058. doi: 10.21037/atm-20-1147 10.21037/atm-20-1147Search in Google Scholar PubMed PubMed Central Nurk, S., Koren, S., Rhie, A., Rautiainen, M., Bzikadze, A. V., Mikheenko, A., et al. (2022). The complete sequence of a human genome. Science 376, 44–53. doi: 10.1126/science.abj6987 10.1126/science.abj6987Search in Google Scholar PubMed PubMed Central Porubsky, D., Harvey, W. T., Rozanski, A. N., Ebler, J., Höps, W., Ashraf, H., et al. (2023). Inversion polymorphism in a complete human genome assembly. Genome Biol. 24, 100. doi: 10.1186/s13059-023-02919-8 10.1186/s13059-023-02919-8Search in Google Scholar PubMed PubMed Central Posey, J. E. (2019). Genome sequencing and implications for rare disorders. Orphanet J. Rare Dis. 14, 153. doi: 10.1186/s13023-019-1127-0 10.1186/s13023-019-1127-0Search in Google Scholar PubMed PubMed Central Singh, T., Poterba, T., Curtis, D., Akil, H., Al Eissa, M., Barchas, J. D., et al. (2022). Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature 604, 509–516. doi: 10.1038/s41586-022-04556-w 10.1038/s41586-022-04556-wSearch in Google Scholar PubMed PubMed Central <span class="reference-mixed-c -Abstract Truncated-

Playing catching up: Proceedings of the 1 st Spanish conference on genomic medicine

Playing catching up: Proceedings of the 1st Spanish conference on genomic medicine

State-of-the-Art Technologies to Interrogate Genetic/Genomic Components of Drug Response

Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study

Tagungsbericht Genomics of Rare Disease 2024 Conference

Unveiling the Landscape of Reportable Genetic Secondary Findings in the Spanish Population: A Comprehensive Analysis Using the Collaborative Spanish Variant Server Database

Integrating Genomics into Healthcare: A Global Responsibility

Precision medicine in relapsed or refractory pediatric solid tumors: a collaborative Spanish initiative

Expert-based collaborative analysis of the situation and prospects of biomarker test implementation in oncology in Spain

Opportunities and Challenges in Interpreting and Sharing Personal Genomes

Actionable mutational profiling in solid tumors using hybrid‐capture‐based next‐generation sequencing in a real‐world setting in Spain

Discovery of novel genetic syndromes in Latin America: Opportunities and challenges

SIEGA the integrated genomic surveillance system of Andalusia, a One Health regional resource connected with the clinic

HGV2012: Leveraging Next-Generation Technology and Large Datasets to Advance Disease Research

[The Spanish participation in the Congresses of the International Society of Urology during the 20th century]

Understanding Parkinson disease in Spain: Genetic and clinical insights

Genomes in clinical care

New Challenges in Drug Discovery – July 8–11, 2019, Vitoria‐Gasteiz, Spain

The Festival of Genetics and Personalized Medicine

From theory to practice: Implementing next-generation sequencing and public health genomics in healthcare systems